United States

Drug manufacturing
#FDA #Manufacturing #United States

US initiative to reduce reliance on foreign drug manufacturing

The US Food and Drug Administration (FDA) has introduced FDA PreCheck, a new programme to facilitate the construction of manufacturing sites.  More than half of pharmaceuticals distributed in the US are manufactured overseas and the US is reliant on overseas sources for active pharmaceutical ingredients (APIs).  “Our gradual overreliance on… Read More

#Business & Investment #News #Regulatory

Vaccine production
#Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines #United States

US cancels mRNA vaccine development contracts

The US Department of Health and Human Services (HHS) has announced the beginning of a “coordinated wind-down” of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA).   The department says the decision follows a comprehensive review of mRNA-related investments initiated during the… Read More

#News #Trending News

#Big pharma #Europe #Pharmaceutical industry #Switzerland #United States

Trump increases pressure on pharma and imposes new tariffs

US President Donald Trump has sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White House said on Thursday.  Trump signed an executive order in May demanding drugmakers cut US medicine prices to match… Read More

#Business & Investment #News #Trending News

Biogen facility in Cambridge, US
#Biogen #Investment #Manufacturing #United States

Biogen commits $2b to modernise US manufacturing facility

Biogen has announced that it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP). The announcement comes at the same time as AstraZeneca also revealed plans to invest in its US facilities. Since breaking ground in 1995, Biogen’s manufacturing in… Read More

#Business & Investment #News #Trending News

Pascal Soriot, Chief Executive Officer, AstraZeneca
#AstraZeneca #Investment #Metabolic diseases #New facility #United States

AstraZeneca invests $50b in US, plans new chronic disease centre

AstraZeneca will invest $50 billion in the United States by 2030, following similar announcements by other big pharma companies.   The company says the investment will create tens of thousands of new, highly skilled direct and indirect jobs across the country powering growth and delivering next generation medicines for patients… Read More

#Business & Investment #News

#Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines #United States

Medical societies sue RF Kennedy Jr for “unlawful” vaccine changes

A group of medical professional societies have filed a lawsuit against Robert F Kennedy Jr in the US District Court for the District of Massachusetts to defend vaccine policy, and to put an end to what they call the Secretary’s “assault on science, public health and evidence-based medicine”. … Read More

#News #Trending News

Drug prices concept
#Biopharmaceuticals #Drug pricing #Pharmaceutical industry #United States

What international reference pricing could mean for US drug costs

Andrew Mignatti, Co-Founder and CEO of careviso, looks at the possibility of the United States (US) adopting international reference pricing and asks if it is possible to lower drug costs without undermining innovation.  Discussion around international reference pricing (IRP) is intensifying as policymakers search for ways to address persistently high… Read More

#Business & Investment #Exclusive Content #Opinion

FDA headquarters
#Fast Track designation #FDA #Regulatory #United States

FDA priority programme reduces drug reviews to two months

The US Food and Drug Administration (FDA) has revealed plans to issue new Commissioner’s National Priority Vouchers (CNPVs) to companies “supporting US national interests”.  The new voucher may be redeemed by drug developers to participate in a novel priority programme that shortens drug review time from approximately 10-12 months to… Read More

#News #Regulatory #Trending News

#Biopharmaceuticals #Generics #Politics #Small molecules #United States

Trump directive aims to cut costs of prescription drugs

US President Trump has signed an executive order designed to lower the cost of prescription drug prices, which includes a win for manufacturers of small molecule drugs.  The order comes one day after the Trump administration instituted a national security report into the pharmaceutical industry, which is likely to be… Read More

#Business & Investment #News #Trending News

#BioMed X #Biomedical research #Funding #National Institutes of Health (NIH) #United States

XBridge Program launches for researchers impacted by NIH cuts

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of its XBridge Program, a fast-track initiative designed to support US-based biomedical researchers impacted by the current NIH funding gaps, hiring freezes, and grant terminations.   The programme is a kind of matchmaking… Read More

#News

USA flag
#Biotech hubs #Biotechnology #Market reporting #United States

Who should we be watching on the USA biotech stage?

Since the inauguration of President Trump in January, the United States has been constantly in the international news, but which US biotech companies are making headlines? Diana Spencer highlights five innovators. According to Cervicorn Consulting, the US biotechnology market size could reach around $1,470.82 billion by 20331  – though it… Read More

#Business & Investment #Exclusive Content #Market Reports

Stand Up for Science, US, March 2025
#Academic #Aix-Marseille Université #Europe #Institut Pasteur #Politics #United States #Vrije Universiteit Brussel

European universities offer scientific refuge to US researchers

Several prestigious European universities are opening their doors to American scientific researchers to provide refuge from what they call “attacks on scientific facts and against researchers”.  The Vrije Universiteit Brussel (VUB) is opening 12 postdoctoral positions for international researchers, which are open to American researchers… Read More

#News #Trending News

#BioInnovation Institute #Biologics / Biotechnology #Biotech hubs #Drug discovery #Funding #Investment #Life sciences #Market reporting #Start-ups #United States

New podcast: Global epicentres of drug discovery innovation

This is the latest episode of the free DDW narrated podcast, titled “Where are the global epicentres of drug discovery innovation?”, which covers two articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Where are the hottest drug discovery hubs in the… Read More

#News

Voting at the ballot box
#India #Life sciences #Market reporting #Politics #UK government #United States

The politics of health: How 2024 elections will impact life sciences

With elections this year in the US, the UK and India – all major players in the life sciences industry – Ivor Campbell, Chief Executive, Snedden Campbell, asks what changes and benefits we can expect to see for companies and their investors, healthcare providers and patients. The global landscape for… Read More

#Exclusive Content #Trends & Analysis